The Wasatch Micro Cap Value Fund—Investor Class lagged the benchmark and finished the quarter with a return of 0.11%. Read ...

We recently compiled a list of the 10 Best Micro Cap Stocks to Buy Now. In this article, we are going to take a look at where ...

With an average annual return of 12.4%, the Oberweis Micro-Cap Fund is the fifth-best-performing US stock fund of the past 25 years. The fund uses a strategy based on an investing phenomenon called ...

Acurx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing antibiotics to treat bacterial infections, with its lead candidate, ibezapolstat, currently in Phase 2b trials ...

All performance information reflects past performance, is presented on a total return basis, net of the Fund's investment advisory fee, and reflects the reinvestment of distributions. Past performance ...

All performance information reflects past performance, is presented on a total return basis, net of the Fund's investment advisory fee, and reflects the reinvestment of distributions. Past performance ...

A significant acquisition in the micro-cap space has propelled the acquiring company to become one of the most actively traded and top percentage gainers on the Nasdaq today—and with good reason.

For the calendar year 2025, Wasatch Micro Cap Fund posted a positive return of 4.83% but the outperformance of lower quality companies within the micro-cap growth universe weighed on relative ...